[go: up one dir, main page]

MX2013000787A - Vectores de parapoxvirus. - Google Patents

Vectores de parapoxvirus.

Info

Publication number
MX2013000787A
MX2013000787A MX2013000787A MX2013000787A MX2013000787A MX 2013000787 A MX2013000787 A MX 2013000787A MX 2013000787 A MX2013000787 A MX 2013000787A MX 2013000787 A MX2013000787 A MX 2013000787A MX 2013000787 A MX2013000787 A MX 2013000787A
Authority
MX
Mexico
Prior art keywords
parapoxvirus
vectors
parapoxvirus vectors
recombinant parapoxviruses
parapoxviruses
Prior art date
Application number
MX2013000787A
Other languages
English (en)
Inventor
Olivier Michel Martinon
Nanda Kumar Damavarapu Reddy
Original Assignee
Zoetis Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Llc filed Critical Zoetis Llc
Publication of MX2013000787A publication Critical patent/MX2013000787A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/863—Poxviral vectors, e.g. entomopoxvirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/175—Canine distemper virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24211—Parapoxvirus, e.g. Orf virus
    • C12N2710/24241—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24243—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a parapoxvirus recombinantes que comprenden ADN heterólogo derivado de un virus del moquillo canino, a la preparación de dichas construcciones y a su uso en composiciones y vacunas inmunogénicas: adicionalmente, se refiere al uso de parapoxvirus recombinantes para diagnosis.
MX2013000787A 2010-07-20 2011-07-18 Vectores de parapoxvirus. MX2013000787A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36587010P 2010-07-20 2010-07-20
PCT/IB2011/053198 WO2012011045A1 (en) 2010-07-20 2011-07-18 Parapoxvirus vectors

Publications (1)

Publication Number Publication Date
MX2013000787A true MX2013000787A (es) 2013-08-08

Family

ID=44504027

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013000787A MX2013000787A (es) 2010-07-20 2011-07-18 Vectores de parapoxvirus.

Country Status (16)

Country Link
US (1) US20120020995A1 (es)
EP (1) EP2595652A1 (es)
JP (1) JP2013537409A (es)
KR (1) KR20130020963A (es)
CN (1) CN103079593A (es)
AR (1) AR082281A1 (es)
AU (1) AU2011281229A1 (es)
BR (1) BR112013001379A2 (es)
CA (1) CA2804890A1 (es)
CL (1) CL2012003737A1 (es)
CO (1) CO6700818A2 (es)
MX (1) MX2013000787A (es)
PH (1) PH12013500122A1 (es)
RU (1) RU2013102413A (es)
UY (1) UY33523A (es)
WO (1) WO2012011045A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102015111756A1 (de) 2015-07-20 2017-01-26 Eberhard Karls Universität Tübingen Medizinische Fakultät Rekombinanter Orf-Virus-Vektor
CN105749272B (zh) * 2016-03-08 2020-05-12 广州动物园 表达大熊猫犬瘟热病毒h、f基因重组山羊痘病毒的疫苗、其制备方法及免疫应用方法
JP6944324B2 (ja) 2017-09-26 2021-10-06 川崎重工業株式会社 鉄道車両構体
CN108220251B (zh) * 2018-02-11 2022-03-04 南方医科大学 一种重组传染性脓疱溶瘤病毒及其制备方法与应用
WO2019170820A1 (en) * 2018-03-07 2019-09-12 Transgene Parapoxvirus vectors
CN111004783A (zh) * 2019-12-18 2020-04-14 内蒙古元山生物科技有限公司 一种表达猪圆环病毒2型cap蛋白的重组羊口疮病毒，其制备方法及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5833975A (en) 1989-03-08 1998-11-10 Virogenetics Corporation Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
US5756102A (en) * 1990-11-20 1998-05-26 Virogenetics Corporation Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants
CN1217027A (zh) 1996-02-28 1999-05-19 拜尔公司 含外源dna的副痘病毒,其制备及其在疫苗中的应用
DE60205388T2 (de) 2001-12-10 2006-03-30 Bavarian Nordic A/S Poxvirus-enthaltende zusammensetzungen und verfahren zu ihrer herstellung
WO2004054614A1 (en) 2002-12-17 2004-07-01 Bayer Healthcare Ag Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom

Also Published As

Publication number Publication date
KR20130020963A (ko) 2013-03-04
JP2013537409A (ja) 2013-10-03
AR082281A1 (es) 2012-11-28
EP2595652A1 (en) 2013-05-29
WO2012011045A1 (en) 2012-01-26
CA2804890A1 (en) 2012-01-26
PH12013500122A1 (en) 2017-08-23
CL2012003737A1 (es) 2013-10-11
UY33523A (es) 2012-02-29
AU2011281229A1 (en) 2013-01-24
CO6700818A2 (es) 2013-06-28
CN103079593A (zh) 2013-05-01
BR112013001379A2 (pt) 2016-05-17
US20120020995A1 (en) 2012-01-26
RU2013102413A (ru) 2014-08-27

Similar Documents

Publication Publication Date Title
MX347997B (es) Vacunas aviares vectorizadas con el virus de la enfermedad de newcastle.
CY1119284T1 (el) ΣΩΜΑΤΙΔΙΑ ΠΑΡΟΜΟΙΑ ΜΕ ΙΟ ΓΛΥΚΟ-ΠΡΩΤΕΪΝΗΣ ΛΥΣΣΑΣ (VLPs)
MX2011011505A (es) Vacuna neumococica y usos de la misma.
MX2021001053A (es) Vacunas contra virus de la influenza y sus usos.
MX2013000787A (es) Vectores de parapoxvirus.
EP3156070A3 (en) Newcastle disease virus vectored herpesvirus vaccines
CL2012000447A1 (es) Composición o vacuna que comprende un vector viral de un paramixovirus aviar 8 (apmv-8) recombinante; método para producir dicho vector; y uso para preparar medicamento útil para inducir una respuesta inmunológica.
CO6670515A2 (es) Vectores de parapoxvirus
NZ608143A (en) Recombinant modified vaccinia virus ankara (mva) influenza vaccine
MX362977B (es) Vectores para la transformacion de mycoplasma hyopneumoniae, cepas transformadas de m. hyopneumoniae, y uso correspondiente.
MX2015007753A (es) Composicion de vacunas para sujetos intactos.
PH12015501378B1 (en) Porcine parvovirus 5a, methods of use and vaccine
BR112015023738B8 (pt) Vacinas de nucleoproteina influenza
ECSP12012131A (es) Método, plasmideo y composición para inducir una respuesta inmune contra virus de la dengue basado en vacunas de adn y virus quiméricos
PH12017501100B1 (en) Recombinant swinepox virus and vaccines
MX2019007924A (es) Vacunas contra la influenza.
MX350718B (es) Vacuna de rinitis equina.
WO2014008475A3 (en) Compositions and methods related to viral vaccines
WO2014015287A3 (en) Influenza vaccine consisting of a mva which expresses influenza antigens fused to vaccinia secretory signal sequences
EP2501405A4 (en) COMPOSITION, METHOD, AND USES OF POX VIRUS ELEMENTS IN VACCINATE CONSTRUCTS
CHENG et al. Selection of Attenuated Vaccine Strain of Duck Paramyxovirus
TR201907091T4 (tr) Yeni adjuvan kompozisyonları.
TN2010000479A1 (en) Inactivated live - attenuated bluetongue virus vaccine
BRPI0800601A2 (pt) método de vacinação dose-reforço para malária que utiliza vìrus recombinantes e composição vacinal

Legal Events

Date Code Title Description
HC Change of company name or juridical status

Owner name: PROXIMAGEN, LLC

FA Abandonment or withdrawal